Jenburkt Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2025 ,inter alia, to consider and approve standalone unaudited financial results for the quarter and half year ended on 30th September, 2025.